← FDA Drug Approvals (Drugs@FDA)
VIVIMUSTA
NDA · New Drug Application · Sponsor: AZURITY · Approved 2022-12-07
Drug application
- FDA Application #
NDA212209- Application type
- New Drug Application
- Brand name
- VIVIMUSTA
- Generic name
- BENDAMUSTINE HYDROCHLORIDE
- Active ingredients
- BENDAMUSTINE HYDROCHLORIDE
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- AZURITY
- Manufacturer
- Azurity Pharmaceuticals, Inc.
- First approval
- 2022-12-07
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown